UBS Group’s Tema Neuroscience and Mental Health ETF MNTL Stock Holding History

UBS Group’s Portfolio MNTL Stock Details MNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-106	Closed	-$2.38K	–	10700
2025 Q2	$2.38K	Buy	106 +77	+266%	+$1.71K	﹤0.01%	9479
2025 Q1	$670	Sell	29 -20	-41%	-$494	﹤0.01%	9695
2024 Q4	$1.2K	Buy	+49	New	+$1.27K	﹤0.01%	9290
2024 Q3	–	Sell	-93	Closed	-$2.39K	–	9861
2024 Q2	$2.39K	Buy	+93	New	+$2.31K	﹤0.01%	8367

UBS Group's MNTL Position: Q3 2025 in Review

UBS Group sold out of Tema Neuroscience and Mental Health ETF (MNTL) in Q3 2025, closing a stake of 106 shares — an estimated $2.38K sold.

UBS Group first reported a position in MNTL in Q2 2024 and held it in 4 quarters. The position peaked at $2.39K in Q2 2024. 0 funds tracked by Wall St. Rank hold MNTL as of Q3 2025.

UBS Group reported no remaining Tema Neuroscience and Mental Health ETF position as of Q3 2025 after selling out during the quarter.
UBS Group sold 106 Tema Neuroscience and Mental Health ETF shares in Q3 2025, an estimated $2.38K.
UBS Group first reported a position in Tema Neuroscience and Mental Health ETF in Q2 2024 and held it in 4 quarters.
UBS Group's Tema Neuroscience and Mental Health ETF position peaked at $2.39K in Q2 2024.
0 funds tracked by Wall St. Rank held Tema Neuroscience and Mental Health ETF as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.